Biogen’s top scientist nearly dares FDA not to approve Alzheimer’s drug

[cafead]

via Biogen’s top scientist offered unflinching support Thursday for the efficacy of the company’s controversial Alzheimer’s drug called aducanumab, shrugging off outside skepticism and almost daring regulators not to approve it.

article source